Title:
An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer
Phase:
III
Contact:
Stephanie Cordeiro de Lima / Study Nurse
Email-Address:
stephanie.cordeirodelima@med.uni-heidelberg.de
Clinical Investigator:
Dr. Stefanie Zschäbitz
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT04223856
EudraCT-Number:
(siehe EU klinisches Studienregister)
2019-004542-15